The Effect of Silver Nitrate Pleurodesis after a Failed Thoracoscopic Talc Poudrage

被引:8
作者
Menna, Cecilia [1 ]
Andreetti, Claudio [2 ]
Ibrahim, Mohsen [2 ]
Maurizi, Giulio [2 ]
Poggi, Camilla [2 ]
Barile, Rocco [2 ]
Cassiano, Francesco [2 ]
Rendina, Erino A. [2 ,3 ]
机构
[1] Univ Aquila, Div Thorac Surg, G Mazzini Hosp Teramo, Fac Med & Surg, I-64100 Teramo, Italy
[2] Univ Roma La Sapienza, Fac Med & Psychol, St Andrea Hosp, Div Thorac Surg, I-00189 Rome, Italy
[3] Fdn Eleonora Lorillard Spencer Cenci, I-00156 Rome, Italy
关键词
MALIGNANT PLEURAL EFFUSIONS; INFLAMMATORY PARAMETERS; MANAGEMENT; PNEUMOTHORAX; TETRACYCLINE;
D O I
10.1155/2013/295890
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. Chemical pleurodesis is the procedure of choice in the management of recurrent malignant pleural effusions (MPE). Talc is probably the most effective sclerosant, with a success rate of 80%. The aim of this study is to demonstrate the effectiveness of silver nitrate solution (SNS) pleurodesis after an unsuccessful thoracoscopic talc poudrage. Methods. Between 2011 and 2013 one hundred and nine patients with unilateral MPE underwent thoracoscopic talc poudrage. Seventeen patients who did not obtain a successful pleurodesis via thoracoscopic procedure were considered for an SNS slurry. The pleural injectate consisted of 100 mL 1% SNS with 10 mL of lidocaine (100 mg/5 mL). The SNS procedure was undertaken once and repeated with the same dose in 5 patients. Results. The duration of follow-up period was 30 days. Subjective pain was low and the same before and after SNS procedure (P value = NS). The mean daily fluid drainage was statistically different (P = 0.001) comparing values before (597.0 +/- 122.8 mL) and after SNS procedure (109.1 +/- 22.3 mL). After 30 days from SNS procedure recurrence of pleural effusion was observed in 2 patients (11%). Conclusions. The present study demonstrates that SNS is an effective agent for producing pleurodesis after a failed thoracoscopic talc poudrage.
引用
收藏
页数:5
相关论文
共 29 条
[1]  
ANDERSEN I, 1959, Acta Chir Scand, V118, P105
[2]   Submucosal injection of the silver-human albumin complex for the treatment of bronchopleural fistula [J].
Andreetti, Claudio ;
D'Andrilli, Antonio ;
Ibrahim, Mohsen ;
Poggi, Camilla ;
Maurizi, Giulio ;
Vecchione, Andrea ;
Venuta, Federico ;
Rendina, Erino A. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (01) :40-43
[3]   BTS guidelines for the management of malignant pleural effusions [J].
Antunes, G ;
Neville, E ;
Duffy, J ;
Ali, N .
THORAX, 2003, 58 :II29-II38
[4]   Bedside Talc Pleurodesis for Malignant Pleural Effusion: Factors Affecting Success [J].
Aydogmus, Umit ;
Ozdemir, Servet ;
Cansever, Levent ;
Sonmezoglu, Yasar ;
Kocaturk, Celalettin Ibrahim ;
Bedirhan, Mehmet Ali .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (03) :745-750
[5]   Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions [J].
Bielsa, Silvia ;
Hernandez, Paula ;
Rodriguez-Panadero, Francisco ;
Taberner, Teresa ;
Salud, Antonieta ;
Porcel, Jose M. .
LUNG, 2011, 189 (02) :151-155
[6]   Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma? [J].
Bilgin, Mehmet ;
Hasdiraz, Leyla ;
Ozkaya, Muharrem ;
Oguzkaya, Fahri .
ANZ JOURNAL OF SURGERY, 2007, 77 (04) :253-255
[7]   RECURRENT AND CHRONIC SPONTANEOUS PNEUMOTHORAX [J].
BROCK, RC .
THORAX, 1948, 3 (02) :88-110
[8]  
Brock RC, 1942, GUYS HOSP REP, V91, P99
[9]   Pleural Effusion in Lung Cancer: More Questions than Answers [J].
Froudarakis, Marios E. .
RESPIRATION, 2012, 83 (05) :367-376
[10]  
HOPKIRK JAC, 1983, AVIAT SPACE ENVIR MD, V54, P158